Intuitive Surgical (NASDAQ:ISRG) EVP Mark Brosius Sells 77 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Mark Brosius sold 77 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $390.67, for a total transaction of $30,081.59. Following the completion of the transaction, the executive vice president owned 1,189 shares in the company, valued at $464,506.63. The trade was a 6.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Brosius also recently made the following trade(s):

• On Wednesday, August 19th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $394.26, for a total transaction of $30,358.02.
• On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $351.00, for a total transaction of $9,828.00.
• On Wednesday, July 29th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $360.21, for a total transaction of $10,085.88.
• On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $344.00, for a total transaction of $9,632.00.
• On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The stock was sold at an average price of $414.13, for a total value of $10,353.25.
• On Wednesday, June 10th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $424.14, for a total transaction of $9,755.22.
• On Monday, June 8th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $420.12, for a total value of $9,662.76.
• On Friday, May 22nd, Mark Brosius sold 18 shares of Intuitive Surgical stock. The shares were sold at an average price of $439.80, for a total value of $7,916.40.

Intuitive Surgical Stock Performance

ISRG stock opened at $397.72 on Thursday. The stock’s fifty day moving average is $389.89 and its two-hundred day moving average is $438.02. The stock has a market capitalization of $140.51 billion, a price-to-earnings ratio of 45.56, a PEG ratio of 2.83 and a beta of 1.46. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. The firm had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. Intuitive Surgical’s revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.81 EPS. As a group, analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have issued reports on ISRG. JPMorgan Chase & Co. decreased their price target on Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a research note on Friday, July 17th. Royal Bank Of Canada cut their price target on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a report on Monday, July 13th. Stifel Nicolaus dropped their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a report on Friday, July 17th. Piper Sandler set a $357.44 price target on shares of Intuitive Surgical in a research report on Monday, July 27th. Finally, Mizuho set a $500.00 target price on Intuitive Surgical and gave the stock a “neutral” rating in a report on Wednesday, July 15th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $508.68.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors have recently bought and sold shares of ISRG. Prosperity Consulting Group LLC grew its position in Intuitive Surgical by 0.5% during the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after purchasing an additional 19 shares in the last quarter. WoodTrust Financial Corp boosted its position in Intuitive Surgical by 0.5% during the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock valued at $2,367,000 after purchasing an additional 20 shares during the last quarter. North Star Investment Management Corp. grew its stake in Intuitive Surgical by 8.5% in the fourth quarter. North Star Investment Management Corp. now owns 269 shares of the medical equipment provider’s stock valued at $152,000 after purchasing an additional 21 shares in the last quarter. Cornerstone Planning Group LLC increased its position in Intuitive Surgical by 11.5% in the 4th quarter. Cornerstone Planning Group LLC now owns 203 shares of the medical equipment provider’s stock worth $106,000 after purchasing an additional 21 shares during the last quarter. Finally, Valeo Financial Advisors LLC raised its stake in shares of Intuitive Surgical by 0.4% during the 4th quarter. Valeo Financial Advisors LLC now owns 4,941 shares of the medical equipment provider’s stock worth $2,798,000 after purchasing an additional 21 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.